Also known as 日本触媒株式会社.
chemXplore tracks 6 projects involving Nippon Shokubai, of which 3 are active.
Nippon Shokubai's role on them: Owner, Investor / Financier, Operator, Developer, and Technology licensor.
2 new construction and 1 expansion.
1 of the active projects carry no start-up date yet.
Licensors are recorded on 1 of these 3 projects For subscribers
Targeting: Lithium bis(fluorosulfonyl)imide (3)
Feasibility study to combine Fol‑Dab8 (folate‑conjugated cationic peptide) with naturally occurring microRNA for oligonucleotide therapeutics; undisclosed equity investment made.
Investment raised to ¥43.0 billion and commercial start pushed to Dec 2028; 3,000 t/yr LiFSI plant; delay and higher material/construction costs cited.
Add 10,000 MT/Y LiFSI capacity at China JV, phased ramp to total 12,400 MT/Y by 2027 to meet rising EV and ESS battery electrolyte demand.
The partnership aims to mass-produce ultrapure LiFSI electrolyte salts for electric vehicle batteries, enhancing performance and supporting Europe's battery value chain. Production starts by end-2025.
The new plants enable consistent AA and SAP production, enhancing supply capability in Europe. SAP demand is growing, especially in Central and Eastern Europe. Production capacity has increased.
The new plants will boost SAP and AA production to meet growing demand, especially in Central and Eastern Europe, increasing global SAP capacity to 710,000 metric tons per year.
Jacobs will provide engineering, procurement, and construction management for a $390M expansion of a Superabsorbent Polymer Plant and new acrylic acid plant in Zwijndrecht, Belgium, completing by Oct 2017.
The investment includes a 100,000 T/Y SAP plant expansion and a new 100,000 T/Y AA plant, enhancing supply stability and increasing global SAP capacity to 710,000 T/Y. Completion by May 2018.
